Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.
Recent developments at Eli Lilly (NYSE:LLY) have highlighted significant strides in both product innovation and operational ...
Eli Lilly CEO Dave Ricks made $114 million last year, according to a new proxy statement, a rare instance of a health ...
From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. But ...
It's been 5 years since the World Health Organization declared COVID-19 a global pandemic ... freedom of expression may ...
Eli Lilly (NYSE:LLY) recently announced its plans to invest $27 billion in four new U.S. manufacturing plants over the next five years, creating thousands of jobs. This move comes at a time when ...
Indianapolis-based Eli Lilly and Co. launched LillyDirect a little more than a year ago and has been ramping up efforts to ...
People hospitalized for a severe bout of COVID-19 are far from in the clear after they've recovered enough to return home, a ...